Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer: a Phase III Randomized Trial

NCT03862170 is registered in ClinicalTrials.gov with CR-CSSS Champlain-Charles-Le Moyne as lead sponsor.

NCT NCT03862170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer: a Phase III Randomized Trial
Lead sponsor
CR-CSSS Champlain-Charles-Le Moyne
Phase
Phase 3
Overall status
Terminated
Start date
February 10, 2015
Completion date
February 28, 2023
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer